Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Pancreatic Neuroendocrine Tumor (NET)
- Can Pancreatic Neuroendocrine Tumors (pNETs) Be Found Early?
- Signs and Symptoms of Pancreatic Neuroendocrine Tumor (pNET)
- Tests for Pancreatic Neuroendocrine Tumors (pNET)
- Pancreatic Neuroendocrine Tumor (pNET) Stages
- Survival Rates for Pancreatic Neuroendocrine Tumors (pNETs)
- Questions to Ask About Pancreatic Neuroendocrine Tumor
- Surgery for Pancreatic Neuroendocrine Tumor (pNET)
- Ablation or Embolization Treatments for Pancreatic Neuroendocrine Tumor
- Radiation Therapy for Pancreatic Neuroendocrine Tumors (pNET)
- Chemotherapy for Pancreatic Neuroendocrine Tumors (pNETs)
- Targeted Drug Therapy for Pancreatic Neuroendocrine Tumors (pNET)
- Drugs Used to Treat Pancreatic Neuroendocrine Tumor (pNET) Symptoms
- Treating Pancreatic Neuroendocrine Tumors (pNETs), Based on Extent of the Tumor
- Active Surveillance for Pancreatic Neuroendocrine Tumors (pNETs)
- If You Have a Pancreatic Neuroendocrine Tumor (NET)
Active Surveillance for Pancreatic Neuroendocrine Tumors (pNETs)
Active surveillance, also known as watchful waiting or watch-and-wait, may be recommended for certain people. This approach is most often recommended for those who have low-grade pancreatic neuroendocrine tumors, which tend to grow slowly and may not cause symptoms or complications for a long time (sometimes months or even years).
Instead of starting treatment right away, the tumor is carefully monitored through regular check-ups. These typically include:
- Physical examinations
- Blood tests
- Imaging tests, such as CT scans (or sometimes MRI)
If active surveillance is considered an option, talk with your doctor about how often you will need to have these tests and scans. Treatment usually begins if there are signs that the tumor is getting bigger and causing symptoms or if it’s spreading.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Gao HL, Wang WQ, Xu HX, Wu CT, Li H, Ni QX, Yu XJ, Liu L. Active surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience. World J Clin Cases. 2020 Sep 6;8(17):3751-3762. doi: 10.12998/wjcc.v8.i17.3751. PMID: 32953851; PMCID: PMC7479574.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors. V.5.2024. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf on March 20, 2025.
Last Revised: March 29, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.